- Home
- GMGI vs IPHA Comparison
GMGI vs IPHA Comparison
Compare GMGI & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- IPHA
- Stock Information
- Founded
- GMGI 2008
- IPHA 1999
- Country
- GMGI United States
- IPHA France
- Employees
- GMGI N/A
- IPHA N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- IPHA Health Care
- Exchange
- GMGI Nasdaq
- IPHA Nasdaq
- Market Cap
- GMGI 145.9M
- IPHA 160.1M
- IPO Year
- GMGI N/A
- IPHA 2019
- Fundamental
- Price
- GMGI $1.01
- IPHA $2.09
- Analyst Decision
- GMGI Strong Buy
- IPHA Hold
- Analyst Count
- GMGI 1
- IPHA 2
- Target Price
- GMGI $4.00
- IPHA $2.00
- AVG Volume (30 Days)
- GMGI 209.6K
- IPHA 13.2K
- Earning Date
- GMGI 11-12-2025
- IPHA 09-17-2025
- Dividend Yield
- GMGI N/A
- IPHA N/A
- EPS Growth
- GMGI N/A
- IPHA N/A
- EPS
- GMGI N/A
- IPHA N/A
- Revenue
- GMGI $172,818,124.00
- IPHA $14,839,695.00
- Revenue This Year
- GMGI $25.28
- IPHA $50.89
- Revenue Next Year
- GMGI $14.90
- IPHA N/A
- P/E Ratio
- GMGI N/A
- IPHA N/A
- Revenue Growth
- GMGI 54.66
- IPHA N/A
- 52 Week Low
- GMGI $0.91
- IPHA $1.29
- 52 Week High
- GMGI $3.06
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- GMGI 43.39
- IPHA 58.17
- Support Level
- GMGI $0.98
- IPHA $2.17
- Resistance Level
- GMGI $1.16
- IPHA $2.40
- Average True Range (ATR)
- GMGI 0.06
- IPHA 0.10
- MACD
- GMGI 0.01
- IPHA 0.02
- Stochastic Oscillator
- GMGI 25.62
- IPHA 57.14
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.